Table 1.
Product | Concentration | Supplier | Catalog number |
---|---|---|---|
Serum-free defined medium (SFDM) | For composition, see Table S1 | ||
A83-01 | 0.5 μM | Sigma-Aldrich | SML0788 |
B27 (without vitamin A) | 1X | Gibco | 12587-010 |
Cholera toxin | 100 ng/mL | Sigma-Aldrich | C8052-.5mg |
FGF2 (=basic FGF) | 20 ng/mL | R&D Systems | 234-FSE |
FGF8 | 200 ng/mL | Peprotech | AF-100-25 |
FGF10 | 100 ng/mL | Peprotech | 100-26 |
L-glutamine | 2 mM | Gibco | 25030081 |
IGF1 | 100 ng/mL | Peprotech | 100-11 |
N2 | 1X | Gibco | 17502-048 |
N-acetyl L-cysteine | 1.25 mM | Sigma-Aldrich | A7250 |
Nicotinamide | 10 mM | Sigma-Aldrich | N0636 |
Noggin | 100 ng/mL | Peprotech | 120-10C |
RSPO1 | 200 ng/mL | Peprotech | 120-38 |
SB202190 | 10 μM | Biotechne (Tocris) | 1264 |
SHH | 100 ng/mL | R&D Systems | 464-SH |
WNT3A | 200 ng/mL | R&D Systems | 5036-WN |
EGFa | 20 ng/ML | R&D Systems | 236-EG |
For all results from Figure 3 onward, TOM was by default supplemented with EGF.